About bio-rad laboratories inc. - BIO.B
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
BIO.B At a Glance
Bio-Rad Laboratories, Inc.
1000 Alfred Nobel Drive
Hercules, California 94547
| Phone | 1-510-724-7000 | Revenue | 2.67B | |
| Industry | Medical Specialties | Net Income | -637,324,000.00 | |
| Sector | Health Technology | Employees | 8,030 | |
| Fiscal Year-end | 12 / 2024 | |||
| View SEC Filings |
BIO.B Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 3.555 |
| Price to Book Ratio | 1.061 |
| Price to Cash Flow Ratio | 25.327 |
| Enterprise Value to EBITDA | 16.121 |
| Enterprise Value to Sales | 3.477 |
| Total Debt to Enterprise Value | 0.151 |
BIO.B Efficiency
| Revenue/Employee | 332,660.274 |
| Income Per Employee | -79,367.87 |
| Receivables Turnover | 5.333 |
| Total Asset Turnover | 0.207 |
BIO.B Liquidity
| Current Ratio | 5.831 |
| Quick Ratio | 4.338 |
| Cash Ratio | 3.085 |
BIO.B Profitability
| Gross Margin | 53.583 |
| Operating Margin | 14.368 |
| Pretax Margin | -31.824 |
| Net Margin | -23.859 |
| Return on Assets | -4.94 |
| Return on Equity | -6.944 |
| Return on Total Capital | -6.281 |
| Return on Invested Capital | -6.046 |
BIO.B Capital Structure
| Total Debt to Total Equity | 16.084 |
| Total Debt to Total Capital | 13.855 |
| Total Debt to Total Assets | 11.431 |
| Long-Term Debt to Equity | 15.61 |
| Long-Term Debt to Total Capital | 13.448 |